|
DE69740140D1
(de)
|
1996-07-24 |
2011-04-14 |
Celgene Corp |
Substituierte 2-(2,6-Dioxopiperidin-3-yl)-phthalimide und Oxoisoindoline und Verfahren zur Verringerung der TNF-Alpha-Stufen
|
|
JP4903922B2
(ja)
|
1997-05-14 |
2012-03-28 |
スローン − ケッタリング インスティチュート フォー キャンサー リサーチ |
選択された蛋白質を分解する複合化合物
|
|
US6306663B1
(en)
|
1999-02-12 |
2001-10-23 |
Proteinex, Inc. |
Controlling protein levels in eucaryotic organisms
|
|
JP2002543129A
(ja)
|
1999-05-05 |
2002-12-17 |
メルク エンド カムパニー インコーポレーテッド |
抗微生物剤としての新規なプロリン類
|
|
EP1322750A4
(en)
|
2000-09-08 |
2004-09-29 |
California Inst Of Techn |
PROTEOLYSIC CHIMERAL PHARMACEUTICAL
|
|
US7208157B2
(en)
|
2000-09-08 |
2007-04-24 |
California Institute Of Technology |
Proteolysis targeting chimeric pharmaceutical
|
|
US20030045552A1
(en)
|
2000-12-27 |
2003-03-06 |
Robarge Michael J. |
Isoindole-imide compounds, compositions, and uses thereof
|
|
JP2005507363A
(ja)
|
2001-02-16 |
2005-03-17 |
イー・アイ・デュポン・ドウ・ヌムール・アンド・カンパニー |
血管新生阻害トリペプチド、組成物およびそれらの使用方法
|
|
GB0106953D0
(en)
*
|
2001-03-20 |
2001-05-09 |
Univ Aberdeen |
Neufofibrillary labels
|
|
HN2002000136A
(es)
|
2001-06-11 |
2003-07-31 |
Basf Ag |
Inhibidores de la proteasa del virus hiv, compuestos que contienen a los mismos, sus usos farmaceuticos y los materiales para su sintesis
|
|
US7030141B2
(en)
|
2001-11-29 |
2006-04-18 |
Christopher Franklin Bigge |
Inhibitors of factor Xa and other serine proteases involved in the coagulation cascade
|
|
WO2004005248A1
(en)
|
2002-07-02 |
2004-01-15 |
Novartis Ag |
Peptide inhibitors of smac protein binding to inhibitor of apoptosis proteins (iap)
|
|
WO2005007621A2
(en)
|
2003-05-30 |
2005-01-27 |
Rigel Pharmaceuticals, Inc. |
Ubiquitin ligase inhibitors
|
|
MXPA06008095A
(es)
|
2004-01-16 |
2007-03-28 |
Univ Michigan |
Mimeticos de smac conformacionalmente restringidos y sus usos.
|
|
CA2558615C
(en)
|
2004-03-23 |
2013-10-29 |
Genentech, Inc. |
Azabicyclo-octane inhibitors of iap
|
|
ME02125B
(me)
|
2004-04-07 |
2013-04-30 |
Novartis Ag |
Inhibitori protein apoptoze (iap)
|
|
CN101035802A
(zh)
|
2004-07-02 |
2007-09-12 |
健泰科生物技术公司 |
Iap抑制剂
|
|
EA019420B1
(ru)
|
2004-12-20 |
2014-03-31 |
Дженентех, Инк. |
Пирролидиновые ингибиторы иап (ингибиторов апоптоза)
|
|
BRPI0607988A2
(pt)
|
2005-02-25 |
2009-10-27 |
Tetralogic Pharmaceuticals |
composto, composição farmacêutica, e método para induzir apoptose em uma célula
|
|
CN100383139C
(zh)
|
2005-04-07 |
2008-04-23 |
天津和美生物技术有限公司 |
可抑制细胞释放肿瘤坏死因子的哌啶-2，6-二酮衍生物
|
|
US20060252698A1
(en)
|
2005-04-20 |
2006-11-09 |
Malcolm Bruce A |
Compounds for inhibiting cathepsin activity
|
|
CA2620085C
(en)
|
2005-08-31 |
2016-07-12 |
Celgene Corporation |
Isoindole-imide compounds and compositions comprising and methods of using the same
|
|
RU2008139192A
(ru)
|
2006-03-03 |
2010-04-10 |
Новартис АГ (CH) |
N-формилгидроксиламины
|
|
WO2007101347A1
(en)
|
2006-03-07 |
2007-09-13 |
Aegera Therapeutics Inc. |
Bir domain binding compounds
|
|
DK2019671T3
(en)
|
2006-05-05 |
2014-12-08 |
Univ Michigan |
Intermediates for the preparation of bivalent SMAC mimetics
|
|
JP2009544620A
(ja)
|
2006-07-20 |
2009-12-17 |
リガンド・ファーマシューティカルズ・インコーポレイテッド |
自己免疫疾患及び炎症のためのプロリン尿素ｃｃｒ１アンタゴニスト
|
|
US20100056495A1
(en)
|
2006-07-24 |
2010-03-04 |
Tetralogic Pharmaceuticals Corporation |
Dimeric iap inhibitors
|
|
RU2448101C2
(ru)
|
2006-08-30 |
2012-04-20 |
Селджин Корпорейшн |
5-замещенные изоиндолиновые соединения
|
|
BRPI0716092A2
(pt)
|
2006-08-30 |
2013-09-17 |
Celgene Corp |
composto ou um sal, solvato, ou estereoisâmero do mesmo, composiÇço farmacÊutica, mÉtodo para tratar, controlar ou prevenir uma doenÇa ou distérbio, e, forma de dosagem de unidade simples.
|
|
CA2668286C
(en)
|
2006-11-03 |
2014-09-16 |
Pharmacyclics, Inc. |
Bruton's tyrosine kinase activity probe and method of using
|
|
WO2008109057A1
(en)
|
2007-03-02 |
2008-09-12 |
Dana-Farber Cancer Institute, Inc. |
Organic compounds and their uses
|
|
EP2079309B1
(en)
|
2007-04-12 |
2015-11-11 |
Joyant Pharmaceuticals Inc |
SMAC MIMEE DIMERS AND TRIMERS USEFUL AS ANTICANCER AGENTS
|
|
NZ580468A
(en)
|
2007-04-13 |
2012-02-24 |
Univ Michigan |
Diazo bicyclic smac mimetics and the uses thereof
|
|
AR066348A1
(es)
|
2007-04-30 |
2009-08-12 |
Genentech Inc |
Inhibidores de las iap
|
|
WO2008144925A1
(en)
|
2007-05-30 |
2008-12-04 |
Aegera Therapeutics Inc. |
Iap bir domain binding compounds
|
|
CN101808693A
(zh)
|
2007-07-25 |
2010-08-18 |
百时美施贵宝公司 |
三嗪激酶抑制剂
|
|
EP2058312A1
(en)
|
2007-11-09 |
2009-05-13 |
Universita' degli Studi di Milano |
SMAC mimetic compounds as apoptosis inducers
|
|
NZ592425A
(en)
|
2008-10-29 |
2013-04-26 |
Celgene Corp |
Isoindoline compounds for use in the treatment of cancer
|
|
WO2010107485A1
(en)
|
2009-03-17 |
2010-09-23 |
The Trustees Of Columbia University In The City Of New York |
E3 ligase inhibitors
|
|
US8691187B2
(en)
*
|
2009-03-23 |
2014-04-08 |
Eli Lilly And Company |
Imaging agents for detecting neurological disorders
|
|
WO2010141805A1
(en)
|
2009-06-05 |
2010-12-09 |
Janssen Pharmaceutica Nv |
Heterocyclic amides as modulators of trpa1
|
|
WO2011008260A2
(en)
|
2009-07-13 |
2011-01-20 |
President And Fellows Of Harvard College |
Bifunctional stapled polypeptides and uses thereof
|
|
EP2784076A1
(en)
|
2009-10-28 |
2014-10-01 |
Joyant Pharmaceuticals, Inc. |
Dimeric SMAC mimetics
|
|
LT3202460T
(lt)
|
2010-02-11 |
2019-10-10 |
Celgene Corporation |
Arilmetoksi izoindolino dariniai ir kompozicijos, apimantys ir jų panaudojimo būdus
|
|
US8198300B2
(en)
*
|
2010-04-29 |
2012-06-12 |
Universidad De Chile |
Method for preventing tau protein aggregation and treating Alzheimer's disease with a quinoline derivative compound
|
|
US9765019B2
(en)
|
2010-06-30 |
2017-09-19 |
Brandeis University |
Small-molecule-targeted protein degradation
|
|
US8809377B2
(en)
|
2010-09-24 |
2014-08-19 |
The Regents Of The University Of Michigan |
Deubiquitinase inhibitors and methods for use of the same
|
|
AR084070A1
(es)
|
2010-12-02 |
2013-04-17 |
Constellation Pharmaceuticals Inc |
Inhibidores del bromodominio y usos de los mismos
|
|
US9500653B2
(en)
|
2010-12-07 |
2016-11-22 |
Yale University |
Small-molecule hydrophobic tagging of fusion proteins and induced degradation of same
|
|
US20140243282A1
(en)
|
2010-12-31 |
2014-08-28 |
Satish Reddy Kallam |
Methods and compositions for designing novel conjugate therapeutics
|
|
JP6016892B2
(ja)
|
2011-04-29 |
2016-10-26 |
セルジーン コーポレイション |
セレブロンを予測因子として使用する癌及び炎症性疾患の治療方法
|
|
US9376425B2
(en)
|
2011-09-27 |
2016-06-28 |
Amgen, Inc. |
Heterocyclic compounds as MDM2 inhibitors for the treatment of cancer
|
|
US20140309265A1
(en)
|
2011-11-09 |
2014-10-16 |
Ensemble Therapeutics |
Macrocyclic compounds for inhibition of inhibitors of apoptosis
|
|
WO2013071039A1
(en)
|
2011-11-09 |
2013-05-16 |
Ensemble Therapeutics |
Macrocyclic compounds for inhibition of inhibitors of apoptosis
|
|
CN104736569A
(zh)
*
|
2012-01-12 |
2015-06-24 |
耶鲁大学 |
通过e3泛素连接酶增强靶蛋白质及其他多肽降解的化合物和方法
|
|
WO2013106646A2
(en)
|
2012-01-12 |
2013-07-18 |
Yale University |
Compounds and methods for the inhibition of vcb e3 ubiquitin ligase
|
|
WO2013170147A1
(en)
|
2012-05-11 |
2013-11-14 |
Yale University |
Compounds useful for promoting protein degradation and methods using same
|
|
WO2013176698A1
(en)
*
|
2012-05-22 |
2013-11-28 |
Eli Lilly And Company |
Carboline and carbazole based imaging agents for detecting neurological dysfunction
|
|
CN104321325B
(zh)
|
2012-05-24 |
2016-11-16 |
诺华股份有限公司 |
吡咯并吡咯烷酮化合物
|
|
CN107540594A
(zh)
|
2012-05-30 |
2018-01-05 |
霍夫曼-拉罗奇有限公司 |
取代的吡咯烷‑2‑甲酰胺
|
|
US9345740B2
(en)
|
2012-07-10 |
2016-05-24 |
Bristol-Myers Squibb Company |
IAP antagonists
|
|
HUE045880T2
(hu)
|
2012-07-31 |
2020-01-28 |
Novartis Ag |
A humán double minute 2 (MDM2) inhibitorra való érzékenységgel összefüggõ markerek
|
|
WO2014025759A1
(en)
|
2012-08-09 |
2014-02-13 |
Bristol-Myers Squibb Company |
Iap antagonists
|
|
TWI586668B
(zh)
|
2012-09-06 |
2017-06-11 |
第一三共股份有限公司 |
二螺吡咯啶衍生物之結晶
|
|
WO2014047024A1
(en)
|
2012-09-18 |
2014-03-27 |
Bristol-Myers Squibb Company |
Iap antagonists
|
|
EP2903998B1
(en)
|
2012-10-02 |
2017-03-15 |
Bristol-Myers Squibb Company |
Iap antagonists
|
|
EP2917218B1
(en)
|
2012-11-09 |
2017-01-04 |
Ensemble Therapeutics Corporation |
Macrocyclic compounds for inhibition of inhibitors of apoptosis
|
|
WO2014100071A2
(en)
|
2012-12-20 |
2014-06-26 |
Merck Sharp & Dohme Corp. |
Substituted pyrrolopyrimidines as hdm2 inhibitors
|
|
TW201429969A
(zh)
|
2012-12-20 |
2014-08-01 |
Merck Sharp & Dohme |
作爲ｈｄｍ２抑制劑之經取代咪唑吡啶
|
|
EP2752191A1
(en)
|
2013-01-07 |
2014-07-09 |
Sanofi |
Compositions and methods using hdm2 antagonist and mek inhibitor
|
|
GB201311910D0
(en)
|
2013-07-03 |
2013-08-14 |
Glaxosmithkline Ip Dev Ltd |
Novel Compounds
|
|
NL2011274C2
(en)
|
2013-08-06 |
2015-02-09 |
Illumicare Ip B V 51 |
Groundbreaking platform technology for specific binding to necrotic cells.
|
|
JP6266659B2
(ja)
|
2013-02-28 |
2018-01-24 |
アムジエン・インコーポレーテツド |
癌の治療のための安息香酸誘導体ｍｄｍ２阻害剤
|
|
US9675697B2
(en)
*
|
2013-03-11 |
2017-06-13 |
The Regents Of The University Of Michigan |
BET bromodomain inhibitors and therapeutic methods using the same
|
|
US9758495B2
(en)
|
2013-03-14 |
2017-09-12 |
Amgen Inc. |
Heteroaryl acid morpholinone compounds as MDM2 inhibitors for the treatment of cancer
|
|
GB201311891D0
(en)
|
2013-07-03 |
2013-08-14 |
Glaxosmithkline Ip Dev Ltd |
Novel compound
|
|
GB201311888D0
(en)
|
2013-07-03 |
2013-08-14 |
Glaxosmithkline Ip Dev Ltd |
Novel compounds
|
|
EP3019517A1
(en)
|
2013-07-12 |
2016-05-18 |
Bristol-Myers Squibb Company |
Iap antagonists
|
|
WO2015110263A1
(en)
*
|
2014-01-21 |
2015-07-30 |
Ac Immune Sa |
Carbazole and carboline compounds for use in the diagnosis, treatment, alleviation or prevention of disorders associated with amyloid or amyolid-like proteins
|
|
US20160058872A1
(en)
|
2014-04-14 |
2016-03-03 |
Arvinas, Inc. |
Imide-based modulators of proteolysis and associated methods of use
|
|
US20180228907A1
(en)
|
2014-04-14 |
2018-08-16 |
Arvinas, Inc. |
Cereblon ligands and bifunctional compounds comprising the same
|
|
AU2015247817C1
(en)
*
|
2014-04-14 |
2022-02-10 |
Arvinas Operations, Inc. |
Imide-based modulators of proteolysis and associated methods of use
|
|
PL3143011T3
(pl)
|
2014-05-13 |
2021-07-19 |
F. Hoffmann-La Roche Ag |
Deuterowane związki heterocykliczne i ich zastosowanie jako środki obrazujące
|
|
TW201613916A
(en)
|
2014-06-03 |
2016-04-16 |
Gilead Sciences Inc |
TANK-binding kinase inhibitor compounds
|
|
US20160022642A1
(en)
|
2014-07-25 |
2016-01-28 |
Yale University |
Compounds Useful for Promoting Protein Degradation and Methods Using Same
|
|
US10071164B2
(en)
|
2014-08-11 |
2018-09-11 |
Yale University |
Estrogen-related receptor alpha based protac compounds and associated methods of use
|
|
US9694084B2
(en)
|
2014-12-23 |
2017-07-04 |
Dana-Farber Cancer Institute, Inc. |
Methods to induce targeted protein degradation through bifunctional molecules
|
|
KR102564925B1
(ko)
|
2015-01-20 |
2023-08-07 |
아비나스 오퍼레이션스, 인코포레이티드 |
안드로겐 수용체의 표적화된 분해를 위한 화합물 및 방법
|
|
US20170327469A1
(en)
|
2015-01-20 |
2017-11-16 |
Arvinas, Inc. |
Compounds and methods for the targeted degradation of androgen receptor
|
|
MX2017009505A
(es)
*
|
2015-02-02 |
2017-11-02 |
Ucb Biopharma Sprl |
Derivados de 9h-pirrolo-dipiridina.
|
|
GB201504314D0
(en)
*
|
2015-03-13 |
2015-04-29 |
Univ Dundee |
Small molecules
|
|
CA2979070A1
(en)
|
2015-03-18 |
2016-09-22 |
Arvinas, Inc. |
Compounds and methods for the enhanced degradation of targeted proteins
|
|
GB201506871D0
(en)
|
2015-04-22 |
2015-06-03 |
Glaxosmithkline Ip Dev Ltd |
Novel compounds
|
|
GB201506872D0
(en)
|
2015-04-22 |
2015-06-03 |
Ge Oil & Gas Uk Ltd |
Novel compounds
|
|
US20180147202A1
(en)
|
2015-06-05 |
2018-05-31 |
Arvinas, Inc. |
TANK-BINDING KINASE-1 PROTACs AND ASSOCIATED METHODS OF USE
|
|
MX2018000360A
(es)
|
2015-07-10 |
2018-06-11 |
Arvinas Inc |
Moduladores basados en mdm2 de proteolisis y metodos de uso asociados.
|
|
EP3322986A4
(en)
|
2015-07-13 |
2018-09-05 |
Arvinas, Inc. |
Alanine-based modulators of proteolysis and associated methods of use
|
|
US10975066B2
(en)
|
2015-07-29 |
2021-04-13 |
UCB Biopharma SRL |
Bis-heteroaryl derivatives as modulators of protein aggregation
|
|
AU2016301195B2
(en)
*
|
2015-08-06 |
2022-09-01 |
Dana-Farber Cancer Institute, Inc. |
Targeted protein degradation to attenuate adoptive T-cell therapy associated adverse inflammatory responses
|
|
US10772962B2
(en)
|
2015-08-19 |
2020-09-15 |
Arvinas Operations, Inc. |
Compounds and methods for the targeted degradation of bromodomain-containing proteins
|
|
GB201516243D0
(en)
|
2015-09-14 |
2015-10-28 |
Glaxosmithkline Ip Dev Ltd |
Novel compounds
|
|
BR112018008918A8
(pt)
|
2015-11-02 |
2019-02-26 |
Univ Yale |
compostos de quimera proteólise dirigida e métodos para preparação e uso dos mesmos
|
|
US20190016703A1
(en)
|
2015-12-30 |
2019-01-17 |
Dana-Farber Cancer Institute, Inc. |
Bifunctional compounds for her3 degradation and methods of use
|
|
AU2017232906B2
(en)
|
2016-03-16 |
2022-03-31 |
H. Lee Moffitt Cancer Center & Research Institute, Inc. |
Small molecules against cereblon to enhance effector T cell function
|
|
US20170281784A1
(en)
|
2016-04-05 |
2017-10-05 |
Arvinas, Inc. |
Protein-protein interaction inducing technology
|
|
WO2017176958A1
(en)
*
|
2016-04-06 |
2017-10-12 |
The Regents Of The University Of Michigan |
Monofunctional intermediates for ligand-dependent target protein degradation
|
|
WO2017184995A1
(en)
|
2016-04-21 |
2017-10-26 |
Bioventures, Llc |
Compounds that induce degradation of anti-apoptotic bcl-2 family proteins and the uses thereof
|
|
AU2017254713C1
(en)
|
2016-04-22 |
2021-04-29 |
Dana-Farber Cancer Institute, Inc. |
Bifunctional molecules for degradation of EGFR and methods of use
|
|
US10865205B2
(en)
*
|
2016-04-22 |
2020-12-15 |
Dana-Farber Cancer Institute, Inc. |
Degradation of cyclin-dependent kinase 8 (CDK8) by conjugation of CDK8 inhibitors with E3 ligase ligand and methods of use
|
|
WO2017197051A1
(en)
|
2016-05-10 |
2017-11-16 |
C4 Therapeutics, Inc. |
Amine-linked c3-glutarimide degronimers for target protein degradation
|
|
US10646488B2
(en)
|
2016-07-13 |
2020-05-12 |
Araxes Pharma Llc |
Conjugates of cereblon binding compounds and G12C mutant KRAS, HRAS or NRAS protein modulating compounds and methods of use thereof
|
|
EP3512842B1
(en)
|
2016-09-15 |
2024-01-17 |
Arvinas, Inc. |
Indole derivatives as estrogen receptor degraders
|
|
WO2018064589A1
(en)
|
2016-09-29 |
2018-04-05 |
Dana-Farber Cancer Institute, Inc. |
Targeted protein degradation using a mutant e3 ubiquitin ligase
|
|
AU2017341723B2
(en)
|
2016-10-11 |
2021-12-16 |
Arvinas Operations, Inc. |
Compounds and methods for the targeted degradation of androgen receptor
|
|
WO2018102067A2
(en)
|
2016-11-01 |
2018-06-07 |
Arvinas, Inc. |
Tau-protein targeting protacs and associated methods of use
|
|
US10925868B2
(en)
|
2016-11-10 |
2021-02-23 |
Dana-Farber Cancer Institute, Inc. |
Degradation of protein kinases by conjugation of protein kinase inhibitors with E3 ligase ligand and methods of use
|
|
SI3689868T1
(sl)
|
2016-12-01 |
2024-02-29 |
Arvinas Operations, Inc. |
Derivati tetrahidronaftalena in tetrahidroizokinolina kot razgrajevalci estrogenskih receptorjev
|
|
BR112019012878A2
(pt)
|
2016-12-23 |
2019-11-26 |
Arvinas Operations Inc |
compostos e métodos para a degradação alvo de polipeptídos de fibrossarcoma rapidamente acelerados
|
|
BR112019012682A2
(pt)
*
|
2016-12-23 |
2019-12-17 |
Arvinas Operations Inc |
moléculas quiméricas visando a proteólise de egfr e métodos associados de uso
|
|
WO2018118598A1
(en)
|
2016-12-23 |
2018-06-28 |
Arvinas, Inc. |
Compounds and methods for the targeted degradation of fetal liver kinase polypeptides
|
|
US11191741B2
(en)
|
2016-12-24 |
2021-12-07 |
Arvinas Operations, Inc. |
Compounds and methods for the targeted degradation of enhancer of zeste homolog 2 polypeptide
|
|
KR20230140606A
(ko)
|
2017-01-26 |
2023-10-06 |
아비나스 오퍼레이션스, 인코포레이티드 |
에스트로겐 수용체 단백질 분해 조절제 및 관련 사용 방법
|
|
BR112019015484A2
(pt)
*
|
2017-01-31 |
2020-04-28 |
Arvinas Operations Inc |
ligantes de cereblon e compostos bifuncionais compreendendo os mesmos
|
|
ES2965049T3
(es)
*
|
2017-07-12 |
2024-04-10 |
Dana Farber Cancer Inst Inc |
Compuestos para la degradación de la proteína tau
|
|
CN109422733A
(zh)
|
2017-09-03 |
2019-03-05 |
上海美志医药科技有限公司 |
一类抑制并降解酪氨酸蛋白激酶alk的化合物
|
|
CN112262134B
(zh)
|
2018-04-13 |
2024-05-24 |
阿尔维纳斯运营股份有限公司 |
小脑蛋白配体和包括其的双官能化合物
|
|
WO2020041331A1
(en)
|
2018-08-20 |
2020-02-27 |
Arvinas Operations, Inc. |
Proteolysis targeting chimeric (protac) compound with e3 ubiquitin ligase binding activity and targeting alpha-synuclein protein for treating neurodegenerative diseases
|
|
JP2022521431A
(ja)
|
2019-02-25 |
2022-04-07 |
シーエイチディーアイ ファウンデーション，インコーポレーテッド |
変異型ハンチンチンタンパク質を標的とするための化合物及びその使用
|